BioSpace News Archive

Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges.

Devyser has today been certified under the new, more comprehensive IVD Regulation that came into force on May 26, 2022.

Abbott (NYSE: ABT) today announced new late-breaking data that show its HeartMate 3™ heart pump extends survival of advanced heart failure patients by at least five years, providing a clear life-saving option for people battling later stage disease.

Gracell Biotechnologies Inc. announced that the management team will participate in and attend one-on-one meetings at four investor conferences in September 2022.

Therapeutic Solutions International announced today data and filing of a patent covering the use of “gene silencing” in treatment of Acute Respiratory Distress Syndrome (ARDS), a leading cause of death in emergency rooms.

Cortechs.ai has received a $1.35 million, 2.5-year grant from the National Institutes of Health (NIH), National Institute on Aging to advance Alzheimer’s Disease (AD) diagnosis.

By Biomarker Type, Safety Biomarkers Are Expected To Be The Maximum Revenue Generating Biomarker And Are Anticipated To Witness A Growth Of 15.9% During Forecast Period

Rise In Research And Development Projects In Various Regions Such As East Asia, South Asia Are Expected To Offer An Opportunity Of US $ 0.5 Bn In 2022-2026 Period.

The global asthma treatment market will rise from a value of ~US$ 25.6 Bn in 2019 to ~US$ 30.5 Bn by 2027, and it is anticipated that an increase in the number of FDA-approved products in parallel to the increasing awareness among asthma patients regarding quality care will drive the steady odyssey of the market.

HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are global health problems. As such, there is growing demand to improve the effectiveness and simplify tests for HIV diagnostics, without compromising on the patient’s quality of life.